Fed Shift Is Major Stock Market RiskStock-Markets / Stock Markets 2015Jun 19, 2015 – 05:43 PM GMTBy: Zeal_LLCThe US stock markets were quick to rally after the Federal Reserve did nothing at its policy meeting this week. Traders love the endless dovishness gushing forth from this Yellen Fed. But their complacency is very misplaced. It was epic Fed easing that […]
–A+Fitbit makes stock market debut, share price jumps by more than 50%By AppleInsider StaffThursday, June 18, 2015, 11:16 am PT (02:16 pm ET)Wearable fitness tracker firm Fitbit, which competes with the Apple Watch with its own hardware, began trading on the New York Stock Exchange Wednesday, and investors promptly drove the company’s share price up by more than 50 percent […]
“Don’t fight the Fed,” unless The Fed says “sell.” That appears to be the message loud and clear from an absolutely exuberant Biotech bubble that is now up over 75% from Janet Yellen’s “stretched valuations” warning last year…Up almost 90% from post-Yellen dip lows…Yellen’s “irrational exuberance” moment.
Nevertheless, valuation metrics in some sectors do appear substantially stretched—particularly those for smaller firms […]
The list of problems with investing in micro-cap biotech stocks begins with extreme volatility and lack of liquidity and ends with the inability to get validation from sophisticated investors who are unable to own such small companies.
Nevertheless, sift through the pile and investors can find gems. Joseph Pantginis of ROTH Capital Partners recognizes the characteristics that make some of these […]
Capitalize on Comeback Stories in Micro-Cap Biotech StocksCompanies / BioTechJun 17, 2015 – 09:55 PM GMTBy: TLSReportThe list of problems with investing in micro-cap biotech stocks begins with extreme volatility and lack of liquidity and ends with the inability to get validation from sophisticated investors who are unable to own such small companies. Nevertheless, sift through the pile and investors […]
By Ben LevisohnSunTrust Robinson Humphrey’s Edward Nash and team offer five biotech stocks for the next six months:
Cempra (CEMP) ($50 PT), our top pick based on near-term clinical and commercial success potential. We recently met with management and it was reiterated that the second Phase III study of solithromycin in CABP (SOLITAIRE-IV) remains on track to report top-line data by […]
By Ben LevisohnSunTrust Robinson Humphrey’s Edward Nash and team offer five biotech stocks for the next six months:
Cempra (CEMP) ($50 PT), our top pick based on near-term clinical and commercial success potential. We recently met with management and it was reiterated that the second Phase III study of solithromycin in CABP (SOLITAIRE-IV) remains on track to report top-line data by […]
More Charts
What does the size of a country’s market tell you about a country’s economy and its standard of living?That’s a question frontier markets strategist Andrew Howell aimed to answer in Citi’s massive new report on global public assets.”Governments should encourage the growth of equity markets, because they tend to be associated with economic development,” Howell wrote. “Whether or not […]
Stock Market Failed Rally?Stock-Markets / Stock Markets 2015Jun 15, 2015 – 02:26 PM GMTBy: Andre_GratianCurrent Position of the MarketSPX: Long-term trend – Bull MarketIntermediate trend – Waiting for confirmation that the ending triangle is complete.Analysis of the short-term trend is done on a daily basis with the help of hourly charts. It is an important adjunct to the analysis of […]
Benchmarks ended the last trading day of the week in the red following a deadlock between Greece and its creditors over the country’s bailout program. Positive consumer sentiment data also raised anxiety about a possible hike in interest rates sooner than later. For the week, the S&P 500 and the Dow ended in the green, while the Nasdaq finished in […]
